Featured Products |
 |
 |
 |
 |
Michael C. Pearce
President and Chief Executive Officer
Michael C. Pearce is a private investor with emphasis on the cleantech and healthcare industries. From December 2007 until March 2010, he led a repositioning of Golf Trust of America, Inc (NYSE Amex: GTA) while serving in the capacity of Chairman and Chief Executive Officer. Over the course of twenty-five years, Mr. Pearce was employed in various technology industry management positions…
Cooper C. Collins
Chief Strategic Officer
Cooper C. Collins has served as President of the Company since January 2007 and became Chief Executive Officer concurrent with the merger with Golf Trust of America, Inc. (“GTA”) on March 9, 2010. Throughout his career with Pernix, Mr. Collins has worked in every capacity from sales…
Michael Venters
Vice President of Corporate Development
Michael Venters has served as Vice President of Corporate Development for the Company since January 2009. Prior to this, Mr. Venters was a founding stockholder of Cornerstone BioPharma/Aristos Pharmaceuticals and served as Vice President of Business Development of Aristos Pharmaceuticals…
Tracy S. Clifford
Corporate Controller and Director of Finance
Tracy Clifford was appointed Corporate Controller & Director of Finance of the Company in December 2011. Ms. Clifford continues to serve as Secretary and Treasurer of the Company. Previously, she was Chief Financial Officer, Secretary and Treasurer of the Company since the merger with Golf Trust of America on March 9, 2010. Ms. Clifford served as the Chief Financial Officer of Golf Trust of America since January 2008 and as GTA’s Secretary since…
Beth Bonner DeVille
Vice President of Sales Training & Compliance
Beth Bonner DeVille was appointed Vice President of Sales Training & Compliance since December 2011. Previously, she was Vice President of Sales and Marketing for the Company since November 2005. Ms.…
Joseph T. Schepers
Director of Investor Relations and Corporate Communications
Mr. Schepers has 20 years of investor relations and corporate communications experience in the healthcare industry, including specialty pharmaceuticals, generics, and biotechnology. He joins Pernix, following four years at Shionogi/Sciele Pharma, as Director of Investor Relations and Corporate…
Robert H. Cline, Jr.
Pharm D., Vice President of Supply Chain Management
Robert Cline has served as Vice President of Supply Chain Management for the Company since October 2009. From July 2007 to October 2009, Mr. Cline led Amneal Pharmaceuticals LLC’s supply chain operations, serving as Vice President of Supply Chain Management from July 2008 to October 2009 and…
Shawn M. Doll
National Sales Director, Pediatric Division
Shawn M. Doll has served as National Sales Director, Pediatric Division for the Company since March 2012. Prior to this, he served in the capacity of East U.S. Director of Sales for the Company from September 2009 to February 2012. Mr. Doll was also a Regional Trainer and Respiratory Therapeutic Specialist for Sepracor from May 2000…
Brandon R. Belanger
National Sales Director, Gastroenterology Division
Brandon R. Belanger has served as National Sales Director, Gastroenterology Division for the Company since March 2012. Prior to this, he served in the capacities of West U.S. Director of Sales from August 2009 to February 2012 and National Sales Manager for Pernix from March 2007 to August 2009. Mr. Belanger’s pharmaceutical career began as a Primary Healthcare Representative for …
Jamison V. Roberts
Director of Government Affairs
Jamison V. Roberts was named Director of Government Affairs on June 1, 2010. Mr. Roberts previously served in various positions at Poly Pharmaceuticals for more than eight years. During that time he held several positions, from Territory Manager to Managed Care Specialist. Recently he served as a…
Leslie White
Director of Regulatory Affairs & Quality Assurance
Leslie White was appointed Director of Regulatory Affairs & Quality Assurance of the Company in December 2011. Mr. White has more than 15 years of experience in clinical and regulatory affairs. Prior to joining Pernix, he served from 2002 to 2011 as the Director of Regulatory Affairs of Trace Life Sciences, a private supplier …